Ophthalmic Considerations in Stevens-Johnson Syndrome.
Department of Pediatrics, Children's Hospital of Savannah, Memorial University Medical Center, Savannah, Georgia.
Laura
L
Thomas
Department of Pediatrics, Children's Hospital of Savannah, Memorial University Medical Center, Savannah, Georgia.
Mark
M
Weng
Department of Ophthalmology, Children's Hospital of Savannah, Memorial University Medical Center, Savannah, Georgia.
Richard
R
Schulze
Department of Ophthalmology, Children's Hospital of Savannah, Memorial University Medical Center, Savannah, Georgia.
Jennifer
J
Bromley
Department of Pediatrics, Children's Hospital of Savannah, Memorial University Medical Center, Savannah, Georgia.
Stephen
S
Thacker
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001684:Biological Dressings; D003231:Conjunctivitis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D016572:Cyclosporine / Q000008:administration & dosage; D004917:Erythromycin / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D013262:Stevens-Johnson Syndrome / Q000150:complications*
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D004917:Erythromycin; D016572:Cyclosporine; D011239:Prednisolone
PROKERA; Stevens-Johnson syndrome; conjunctivitis; symblepharon